Crinetics Pharmaceuticals Inc.

16.73-0.5900-3.41%Vol 139.43K1Y Perf 7.95%
Apr 16th, 2021 16:00 DELAYED
BID16.66 ASK16.73
Open17.27 Previous Close17.32
Pre-Market- After-Market-
 - -  - -%
Target Price
33.60 
Analyst Rating
Strong Buy 1.00
Potential %
100.84 
Finscreener Ranking
★★★★+     56.11
Insiders Trans % 3/6/12 mo.
-/100/- 
Value Ranking
★★★★     55.52
Insiders Value % 3/6/12 mo.
-/100/-78 
Growth Ranking
★★★     51.97
Insiders Shares Cnt. % 3/6/12 mo.
-/100/-75 
Income Ranking
 —    -
Market Cap552.58M 
Earnings Rating
Sell
Price Range Ratio 52W %
42.35 
Earnings Date
14th May 2021

Today's Price Range

16.5517.45

52W Range

11.6123.70

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-1.99%
1 Month
1.39%
3 Months
17.73%
6 Months
-1.88%
1 Year
7.95%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CRNX16.73-0.5900-3.41
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
16.50
16.90
0.02
0.02
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-
-17 442.90
-17 200.00
-22 154.70
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-67.78
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.58-0.66-13.79
Q03 2020-0.52-0.56-7.69
Q02 2020-0.52-0.53-1.92
Q01 2020-0.63-0.71-12.70
Q04 2019-0.67-0.6010.45
Q03 2019-0.54-0.60-11.11
Q02 2019-0.45-0.51-13.33
Q01 2019-0.39-0.375.13
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.64-6.67Negative
6/2021 QR-0.65-4.84Negative
12/2021 FY-2.66-12.71Negative
12/2022 FY-3.16-8.22Negative
Next Report Date14th May 2021
Estimated EPS Next Report-0.65
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume139.43K
Shares Outstanding33.03M
Trades Count1.19K
Dollar Volume1.37M
Avg. Volume141.92K
Avg. Weekly Volume200.84K
Avg. Monthly Volume189.73K
Avg. Quarterly Volume141.20K

Crinetics Pharmaceuticals Inc. (NASDAQ: CRNX) stock closed at 16.73 per share at the end of the most recent trading day (a -3.41% change compared to the prior day closing price) with a volume of 140.36K shares and market capitalization of 552.58M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 68 people. Crinetics Pharmaceuticals Inc. CEO is R. Scott Struthers.

The one-year performance of Crinetics Pharmaceuticals Inc. stock is 7.95%, while year-to-date (YTD) performance is 18.57%. CRNX stock has a five-year performance of %. Its 52-week range is between 11.61 and 23.7, which gives CRNX stock a 52-week price range ratio of 42.35%

Crinetics Pharmaceuticals Inc. currently has a PE ratio of -7.30, a price-to-book (PB) ratio of 3.50, a price-to-sale (PS) ratio of 7 136.26, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -45.37%, a ROC of -41.91% and a ROE of -49.80%. The company’s profit margin is -%, its EBITDA margin is -17 200.00%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Crinetics Pharmaceuticals Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.65 for the next earnings report. Crinetics Pharmaceuticals Inc.’s next earnings report date is 14th May 2021.

The consensus rating of Wall Street analysts for Crinetics Pharmaceuticals Inc. is Strong Buy (1), with a target price of $33.6, which is +100.84% compared to the current price. The earnings rating for Crinetics Pharmaceuticals Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Crinetics Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Crinetics Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.92, ATR14 : 1.13, CCI20 : 70.29, Chaikin Money Flow : -0.07, MACD : 0.32, Money Flow Index : 59.86, ROC : 8.35, RSI : 49.71, STOCH (14,3) : 42.95, STOCH RSI : 0.59, UO : 46.29, Williams %R : -57.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Crinetics Pharmaceuticals Inc. in the last 12-months were: R. Scott Struthers (Buy at a value of $65 000), R. Scott Struthers (Sold 35 000 shares of value $520 830 ), Wendell D. Wierenga (Option Excercise at a value of $18 490)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (83.33 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
1 (16.67 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.33
Strong Buy
1.40

Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

CEO: R. Scott Struthers

Telephone: +1 858 450-6464

Address: 10222 Barnes Canyon Road, San Diego 92121, CA, US

Number of employees: 68

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

52%48%

Bearish Bullish

45%55%

News

Stocktwits